Alpa Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alpa Laboratories held its 37th AGM on September 29, 2025, via video conferencing, and all proposed resolutions were passed with full majority. Members adopted the audited standalone and consolidated financial statements for the financial year ended March 31, 2025, and re-appointed Mr. Shitul Shah (DIN: 07883973) as director, who retires by rotation. The remuneration of M/s Sudeep Saxena and Associates as Cost Auditors was ratified at Rs. 70,000 per year for FY 2025-26, and M/s Shilpesh Dalal & Co. was appointed as Secretarial Auditor. A notable special resolution was passed authorising the Board under Section 186 of the Companies Act, 2013, to give loans, guarantees, or acquire securities of any body corporate up to an aggregate outstanding of Rs. 160 crores at any time. Remote e-voting was conducted from September 26 to September 28, 2025, with Mr. Shilpesh Dalal acting as scrutiniser.
The Rs. 160 crore lending/investment authorisation granted to the Board is a significant fresh capacity and could point to upcoming expansion, acquisitions, or strategic investments, which shareholders should watch closely. The smooth passing of all routine resolutions including re-appointment of the director and auditor ratifications suggests no governance concerns at this stage.